In healthy people in their early 60s, having higher insulin resistance (where the body's cells don't respond well to insulin) goes along with lower sugar use in many brain areas, especially in the left inner part of the temporal lobe. This means the brain cells in those regions get less energy.
See the scientific wording
Among cognitively normal late middle-aged adults (mean age 60.7 years), higher insulin resistance is associated with lower regional cerebral glucose metabolism in extensive regions of the frontal, lateral parietal, lateral temporal, and medial temporal lobes, as well as the cerebellum, with the strongest association observed in the left medial temporal lobe (R² = 0.178).
Correlational — new studies may shift this
ObservationalOne low-scoring study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cross-Sectional StudyHuman2015
The study found that people with higher insulin resistance had less brain activity in areas important for thinking and memory, especially in a part of the brain called the medial temporal lobe, which is exactly what the claim says.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
When the body becomes resistant to insulin, the brain also becomes less responsive to insulin. Insulin normally helps brain cells take in sugar from the blood to use for energy. When brain cells become insulin-resistant, they can't take in as much sugar, so the brain's energy supply drops. This is especially noticeable in areas important for memory, like the medial temporal lobe. As a result, memory and thinking can suffer.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In healthy people in their early 60s, having higher insulin resistance (where the body's cells don't respond well to insulin) goes along with lower sugar use in many brain areas, especially in the left inner part of the temporal lobe. This means the brain cells in those regions get less energy.
Mechanism
1 studyThe main way insulin resistance hurts the brain is by making brain cells less responsive to insulin. Insulin normally helps brain cells take in sugar for energy. When they become resistant, the brain can't use sugar well, especially in memory areas. Other things like harmful proteins or cell damage might also be involved, but the direct effect on sugar use is the best-supported reason.
When the body becomes resistant to insulin, the brain also becomes less responsive to insulin. Insulin normally helps brain cells take in sugar from the blood to use for energy. When brain cells become insulin-resistant, they can't take in as much sugar, so the brain's energy supply drops. This is especially noticeable in areas important for memory, like the medial temporal lobe. As a result, memory and thinking can suffer.
Peripheral insulin resistance leads to reduced insulin signaling in the brain, either because less insulin crosses the blood-brain barrier or because brain cells become less sensitive to insulin.
Reduced insulin signaling in neurons impairs their ability to take up and use glucose from the blood, lowering the rate of cerebral glucose metabolism in vulnerable regions.
Lower glucose metabolism in memory-critical regions, particularly the medial temporal lobe, impairs memory function.
Less supported by current evidence, but not ruled out
Insulin resistance can lead to a buildup of a harmful protein called amyloid in the brain. This protein clumps together and damages brain cells, especially in areas used for memory. When these cells are damaged, they can't use sugar properly, so the brain's energy supply drops.
Peripheral insulin resistance increases the production or reduces the clearance of amyloid-beta peptides in the brain.
Amyloid-beta aggregates form plaques that disrupt synaptic function and are toxic to neurons.
Damaged neurons have impaired glucose metabolism and die, leading to reduced regional glucose metabolism and cognitive decline.
Insulin resistance can cause problems with the mitochondria, the part of cells that make energy. Without enough energy, brain cells can't work properly, and they can't use sugar efficiently. This leads to lower brain activity, especially in memory areas.
Insulin resistance causes mitochondrial dysfunction in neurons, impairing oxidative phosphorylation and ATP production.
Reduced ATP production impairs the neuron's ability to maintain ion gradients and synaptic transmission, increasing vulnerability to damage.
Impaired neurons show reduced glucose utilization and eventual degeneration, leading to lower regional glucose metabolism.
Insulin resistance can cause more oxidative stress and inflammation in the brain. These processes create harmful substances that damage brain cells. When brain cells are damaged, they can't use sugar normally, and the brain's energy supply drops, leading to memory problems.
Insulin resistance increases oxidative stress and neuroinflammation in the brain.
This leads to damage of neurons and synapses, impairing their function and glucose utilization.
Damaged neurons result in reduced glucose metabolism in affected regions and cognitive decline.
Evidence from Studies
Supporting (1)
Community contributions welcome
Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for Alzheimer’s disease
The study found that people with higher insulin resistance had less brain activity in areas important for thinking and memory, especially in a part of the brain called the medial temporal lobe, which is exactly what the claim says.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of Observational Studies Examining Insulin Resistance and Regional Cerebral Glucose Metabolism in Middle-Aged Adults
Comprehensive literature search for cohort and cross-sectional studies that measured insulin resistance (e.g., HOMA-IR) and regional cerebral glucose metabolism (e.g., FDG-PET) in cognitively normal middle-aged adults, with meta-analysis of effect sizes.
Prospective Cohort Study of Insulin Resistance and Longitudinal Changes in Cerebral Glucose Metabolism in Cognitively Normal Middle-Aged Adults
Enroll cognitively normal late middle-aged adults (mean age ~60 years), measure insulin resistance (HOMA-IR) and FDG-PET at baseline, then follow up with repeated FDG-PET over 5-10 years to assess whether baseline insulin resistance predicts decline in regional metabolism.
Cross-Sectional Study of Insulin Resistance and Regional Cerebral Glucose Metabolism in Cognitively Normal Late Middle-Aged Adults
Recruit a large sample of cognitively normal adults aged 50-70, measure insulin resistance (HOMA-IR) and perform FDG-PET to quantify regional glucose metabolism, then analyze associations adjusting for demographics and vascular risk factors.